Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Dyax Corp. (DYAX)

-NasdaqGM
15.11 Down 0.37(2.39%) Feb 27, 4:00PM EST
|After Hours : 15.11 Down 0.00 (0.01%) Feb 27, 4:38PM EST
Add to Portfolio
Prev Close:15.48
Open:15.40
Bid:N/A
Ask:17.50 x 100
1y Target Est:17.06
Beta:0.48
Earnings Date:Apr 28 - May 4 (Est.)
Day's Range:14.88 - 15.94
52wk Range:6.05 - 17.20
Volume:998,374
Avg Vol (3m):976,762
Market Cap:2.06B
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 2.39%2.06B
SHPGDown 2.39%47.33B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.18
Quarterly EPS Est (Mar-15) :-0.05
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-4.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback